Reference 2018-306

REF:            2018-306

Subject:        Intra-vitreal injections/implants

 

 

Request:

Dear Bolton NHS Foundation Trust,

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January to April 2018

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total          
Wet Age Related Macular Degeneration (wAMD)          
Diabetic Macular Oedema (DMO)          
Retinal Vein Occlusion – Central or Branch (CRVO or BRVO)          
Other eg mCNV          

 

 

 

Response:

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total  858  0  1027  1 23 
We are unable to breakdown by disease.